Ritika Agarwal

Hi, sir. Thank you for taking my question. First question is what we understood is you're expanding capacity in almost all of these segments, which is DDC, injectables, soft gel, and biologics maybe going ahead. Could you help us understand what is the ca pacity utilization currently for each of these segments?

Got it, sir. So, we should understand DDC and injectables are running probably at the peak capacity, while soft gelatin we are adding capacity to serve the CDMO demand. But apart from that, of the current 2 billion kind of capacity, what should be our current capacity utilization for soft gel?

Yes, yes, on the current capacity.